MENU
免責聲明
本網站僅提供窩客幫資訊參考平台， 並不涉入其中任何諮詢、交易。本網站對各該窩客幫相關資訊亦不作任何實質或形式上之審查。本網站中所載一切窩客幫的資訊、文字、照片、圖形 、產權、廣告內容、或其他資料（以下簡稱『內容』）。無論其為公開張貼或私下傳送，若有不實或違法情事，均為『內容』提供者之責任，窩客幫概不負責也不承擔任何法律責任。

豐華生物科技股份有限公司
豐華生物科技股份有限公司
文章管理
Glac Biotech Bifidobacterium animalis subsp. Lactis CP-9 Shines with New Achievements
Over the years, our star probiotic strains have been highly acclaimed in the probiotic industry for their stable high quality and production technology, and have attracted high levels of interest at international exhibitions. In 2023, we were even nominated for the NutraIngredients Europe Awards, known as the "Oscars" of the food industry, alongside the world's top probiotic manufacturers, once again receiving global recognition for our top-quality strains. In recent years, our research and development center has continued to invest in developing our strains, conducting clinical studies on our animal-derived bifidobacterium strain, B. animalis subsp. Lactis CP-9, for the treatment and prevention of neonatal jaundice, and earning patent honors.
 
回上一頁
相關文章
豐華生物科技股份有限公司
電話 : +886-6-589-1876 連絡人: 林榮錦 地址 : 1 F., No. 139, Sanmin St., Xinshi Dist., Tainan City 744007, Taiwan (R.O.C.) 信箱 : glac@glac.com.tw
  • 服務項目

  • 特別關鍵字